Search

everythinglearnresearchcommunity

for

Search:↓

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Erianin may effectively treat alopecia areata by targeting the immune system.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

UV light helped human hair transplants survive in mice without broad immunosuppression.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Th22 cells are essential for Tβ15-induced hair growth in mice.